---
figid: PMC8725472__12935_2021_2402_Fig8_HTML
figtitle: SCUBE3 downregulation modulates hepatocellular carcinoma by inhibiting CCNE1
  via TGFB/PI3K/AKT/GSK3B pathway
organisms:
- NA
pmcid: PMC8725472
filename: 12935_2021_2402_Fig8_HTML.jpg
figlink: /pmc/articles/PMC8725472/figure/Fig8/
number: F8
caption: 'Schematic diagram of the validation hypothesis of this study: SCUBE3 activates
  the PI3K/AKT pathway by binding to the TGFβRII receptor to phosphorylate GSK3β to
  inhibit its kinase activity, thereby inhibiting the ubiquitination of CCNE1, leading
  to the accumulation of CCNE1 and ultimately promoting the proliferation of liver
  cancer cells'
papertitle: SCUBE3 downregulation modulates hepatocellular carcinoma by inhibiting
  CCNE1 via TGFβ/PI3K/AKT/GSK3β pathway.
reftext: Pan Xu, et al. Cancer Cell Int. 2022;22:1.
year: '2022'
doi: 10.1186/s12935-021-02402-z
journal_title: Cancer Cell International
journal_nlm_ta: Cancer Cell Int
publisher_name: BioMed Central
keywords: Hepatocellular carcinoma | SCUBE3 | AKT | CCNE1 | Cell proliferation
automl_pathway: 0.9451749
figid_alias: PMC8725472__F8
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC8725472__F8
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8725472__12935_2021_2402_Fig8_HTML.html
  '@type': Dataset
  description: 'Schematic diagram of the validation hypothesis of this study: SCUBE3
    activates the PI3K/AKT pathway by binding to the TGFβRII receptor to phosphorylate
    GSK3β to inhibit its kinase activity, thereby inhibiting the ubiquitination of
    CCNE1, leading to the accumulation of CCNE1 and ultimately promoting the proliferation
    of liver cancer cells'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SCUBE3
  - TGFBR1
  - GSK3A
  - GSK3B
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - TGFBR2
  - CCNE1
  - CDK2
---
